These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation. Rybakowska I, Bakuła S, Klimek J, Milczarek R, Smolenski RT, Kaletha K. Nucleosides Nucleotides Nucleic Acids; 2010 Jun 01; 29(4-6):453-6. PubMed ID: 20544536 [Abstract] [Full Text] [Related]
5. Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle. Hanisch F, Hellsten Y, Zierz S. Biol Chem; 2006 Jan 01; 387(1):53-8. PubMed ID: 16497164 [Abstract] [Full Text] [Related]
6. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization. Andreassi MG, Botto N, Laghi-Pasini F, Manfredi S, Ghelarducci B, Farneti A, Solinas M, Biagini A, Picano E. Int J Cardiol; 2005 May 25; 101(2):191-5. PubMed ID: 15882662 [Abstract] [Full Text] [Related]
7. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients. de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C. Am Heart J; 2006 Oct 25; 152(4):736-41. PubMed ID: 16996850 [Abstract] [Full Text] [Related]
9. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome). Gastmann A, Sigusch HH, Henke A, Reinhardt D, Surber R, Gastmann O, Figulla HR. Am J Cardiol; 2004 May 15; 93(10):1260-4. PubMed ID: 15135700 [Abstract] [Full Text] [Related]
10. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure. Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL. J Card Fail; 2005 Dec 15; 11(9):677-83. PubMed ID: 16360962 [Abstract] [Full Text] [Related]
11. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases. Safranow K, Suchy J, Jakubowska K, Olszewska M, Bińczak-Kuleta A, Kurzawski G, Rzeuski R, Czyżycka E, Łoniewska B, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D. J Appl Genet; 2011 Feb 15; 52(1):67-76. PubMed ID: 21108053 [Abstract] [Full Text] [Related]
12. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients. Collins RP, Palmer BR, Pilbrow AP, Frampton CM, Troughton RW, Yandle TG, Skelton L, Richards AM, Cameron VA. Am Heart J; 2006 Aug 15; 152(2):312-20. PubMed ID: 16875916 [Abstract] [Full Text] [Related]
14. Is the C34T polymorphism of the AMPD1 gene associated with athlete performance in rowing? Ciȩszczyk P, Eider J, Ostanek M, Leońska-Duniec A, Ficek K, Kotarska K, Girdauskas G. Int J Sports Med; 2011 Dec 15; 32(12):987-91. PubMed ID: 22105616 [Abstract] [Full Text] [Related]
15. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Hart N. J Am Coll Cardiol; 2000 Oct 15; 36(4):1248-52. PubMed ID: 11028479 [Abstract] [Full Text] [Related]
17. Association between the C34T polymorphism of the AMPD1 gene and essential hypertension in Malaysian patients. Nemati R, Lu J, Ramachandran V, Etemad A, Heidari M, Yahya MJ, Roozafzoon R, Ismail P. Genet Mol Res; 2016 Jun 20; 15(2):. PubMed ID: 27323204 [Abstract] [Full Text] [Related]